Article Text

PDF

How Good at Neurology are you? – Answers
  1. Paul Goldsmith*,
  2. Graham Lennox*,
  3. Julian Ray
  1. *Departments of Neurology and
  2. Neurophysiology, Addenbrooke’s Hospital, Cambridge, UK. Email; pg255{at}hermes.cam.ac.uk; drslennox{at}aol.com; j.l.ray{at}medschl.cam.ac.uk

    Abstract

    1.

    (d) (HIT)

    HIT or heparin induced thrombocytopenia, is divided into type I and II. Type I consists of a mild non-immune thrombocytopenia, often seen within a few days of starting heparin. This is typically transient, requires no intervention and improves despite continued heparin administration. Type II, in contrast, is an immune-mediated, idiosyncractic reaction with potentially severe consequences. Severe thrombocytopenia with haemorrhage, purpura and a platelet count of less than 20, is uncommon, with the complications coming mainly from the associated thrombotic tendency. Both arterial and venous thromboses occur. The thromboses may be seen even with a ‘normal’, albeit falling platelet count. Onset is usually 5–14 days after starting heparin, but can occur earlier if there has been previous heparin exposure. HIT may also occur with low molecular weight heparin, albeit more rarely. Treatment is to stop the heparin and give an alternative anticoagulant.

    PNH: paroxysmal nocturnal haemoglobinuria. Chronic

    Statistics from Altmetric.com

    Request permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.